4//SEC Filing
Culley Brian M 4
Accession 0001493152-22-009000
CIK 0000876343other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:05 PM ET
Size
11.5 KB
Accession
0001493152-22-009000
Insider Transaction Report
Form 4
Culley Brian M
DirectorPresident and CEO
Transactions
- Tax Payment
Common Shares, no par value
2022-03-31$1.54/sh−5,343$8,228→ 91,387 total - Exercise/Conversion
Restricted Stock Units
2022-03-31−15,450→ 15,450 totalExercise: $0.00→ Common Shares (15,450 underlying) - Exercise/Conversion
Common Shares, no par value
2022-03-31+15,450→ 96,730 total - Purchase
Common Shares, no par value
2022-03-31$1.53/sh+6,400$9,792→ 97,787 total
Footnotes (5)
- [F1]Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis.
- [F2]Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.
- [F3]Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.
- [F4]The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.52 to not more than $1.54. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F5]The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001310683
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:05 PM ET
- Size
- 11.5 KB